ATE70301T1 - Gewebeplasminogen-aktivator-mutant, dafuer kodierende rekombinante genetische information und verfahren zur herstellung dieser mutanten, deren verwendung und pharmazeutische zusammensetzungen. - Google Patents

Gewebeplasminogen-aktivator-mutant, dafuer kodierende rekombinante genetische information und verfahren zur herstellung dieser mutanten, deren verwendung und pharmazeutische zusammensetzungen.

Info

Publication number
ATE70301T1
ATE70301T1 AT86200223T AT86200223T ATE70301T1 AT E70301 T1 ATE70301 T1 AT E70301T1 AT 86200223 T AT86200223 T AT 86200223T AT 86200223 T AT86200223 T AT 86200223T AT E70301 T1 ATE70301 T1 AT E70301T1
Authority
AT
Austria
Prior art keywords
mutants
pharmaceutical compositions
plasminogen activator
genetic information
production
Prior art date
Application number
AT86200223T
Other languages
English (en)
Inventor
Hans Pannekoek
Arnoldus Johannes G Veerman
Anton Jan Van Zonneveld
Original Assignee
Stichting Centraal Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8195701&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE70301(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stichting Centraal Lab filed Critical Stichting Centraal Lab
Application granted granted Critical
Publication of ATE70301T1 publication Critical patent/ATE70301T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT86200223T 1986-02-17 1986-02-17 Gewebeplasminogen-aktivator-mutant, dafuer kodierende rekombinante genetische information und verfahren zur herstellung dieser mutanten, deren verwendung und pharmazeutische zusammensetzungen. ATE70301T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP86200223A EP0234051B1 (de) 1986-02-17 1986-02-17 Gewebeplasminogen-Aktivator-Mutant, dafür kodierende rekombinante genetische Information und Verfahren zur Herstellung dieser Mutanten, deren Verwendung und pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE70301T1 true ATE70301T1 (de) 1991-12-15

Family

ID=8195701

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86200223T ATE70301T1 (de) 1986-02-17 1986-02-17 Gewebeplasminogen-aktivator-mutant, dafuer kodierende rekombinante genetische information und verfahren zur herstellung dieser mutanten, deren verwendung und pharmazeutische zusammensetzungen.

Country Status (4)

Country Link
EP (1) EP0234051B1 (de)
JP (1) JPS62192323A (de)
AT (1) ATE70301T1 (de)
DE (1) DE3682891D1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108909A (en) * 1985-03-22 1992-04-28 Chiron Corporation Expression of TPA in mammalian cells
GB8508717D0 (en) * 1985-04-03 1985-05-09 Beecham Group Plc Composition
US5234686A (en) * 1985-04-03 1993-08-10 Beecham Group P.L.C. Human tissue plasminogen activator consisting essentially of t-PA residues to 160 to 527, pharmaceutical compositions and methods of treatment
ZA869626B (en) * 1985-12-23 1987-10-28 Chiron Corp Peptide plasminogen activators
ATE90967T1 (de) * 1986-03-28 1993-07-15 Creative Biomolecules Inc Proteinanaloge des gewebs-plasminogenaktivators.
US5047241A (en) * 1986-07-11 1991-09-10 American Home Products Corporation Tris-Kringle plasminogen activator with novel K2 insert
US5580559A (en) * 1986-12-05 1996-12-03 Ciba-Geigy Corporation Hybrid plasminogen activator
US5242819A (en) * 1986-12-05 1993-09-07 Ciba-Geigy Corporation DNA molecules encoding hybrid proteins of tissue plasminogen activator and urokinase
SE8702562L (sv) * 1987-06-18 1988-12-19 Kabigen Ab Nya fibrinolytiska enzymer
US5244676A (en) * 1987-10-09 1993-09-14 Monsanto Company Modified tissue plasminogen activator with modified glycosylation site
US4963357A (en) * 1987-10-09 1990-10-16 Monsanto Company Tissue plasminogen activator modified by the substitution of Arg for Cys at position 73, methods and pharmaceutical compositions therefor
US5037752A (en) * 1987-10-09 1991-08-06 Monsanto Company Modified tissue plasminogen activator substituted at cysteine-73 and lysine-277
EP0311589B1 (de) * 1987-10-09 1994-03-23 Monsanto Company Modifizierter Gewebeplasminogenaktivator
US5100666A (en) * 1987-10-09 1992-03-31 Monsanto Company Modified tissue plasminogen activator K2K2SP
US5094953A (en) * 1988-03-21 1992-03-10 Genentech, Inc. Human tissue plasminogen activator variants
AU3876789A (en) * 1988-06-20 1990-01-12 Washington University Use of modified tpa to detect blood clots
DE3836200A1 (de) * 1988-10-24 1990-04-26 Boehringer Mannheim Gmbh Domaenenduplikations-muteine des gewebsplasminogen-aktivators (t-pa)
ATE123057T1 (de) * 1988-10-27 1995-06-15 Tno Trombolytischer wirkstoff mit modifikation der domäne der kringle.
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
CA2047063A1 (en) * 1991-07-15 1993-01-16 Warren C. Mackellar Method for folding tissue plasminogen activators and erivatives thereof
EP1380290A1 (de) 2002-07-09 2004-01-14 Universitair Medisch Centrum Utrecht Cross-Beta-Strukturweg und seine therapeutische Relevanz
US8114832B2 (en) 2005-07-13 2012-02-14 Crossbeta Biosciences B.V. Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition
ATE554394T1 (de) 2005-07-13 2012-05-15 Crossbeta Biosciences Bv Cross-beta-struktur-bindende verbindungen
WO2025262265A1 (en) 2024-06-21 2025-12-26 Etablissement Francais Du Sang Chimeric molecules comprising an anti-fibrin antibody and an antithrombotic molecule

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79202B (de) * 1982-05-05 1984-10-22 Genentech Inc
EP0207589A1 (de) * 1985-04-03 1987-01-07 Beecham Group Plc Modifiziertes fibrinolytisches Enzym
US4916071A (en) * 1985-08-14 1990-04-10 American Home Products Corporation Poly-kringle plasminogen activator
WO1987003906A1 (en) * 1985-12-20 1987-07-02 The Upjohn Company Tissue plasminogen activator (tpa) analogs
ZA869626B (en) * 1985-12-23 1987-10-28 Chiron Corp Peptide plasminogen activators
DE3789664T3 (de) * 1986-01-31 2004-09-16 Genetics Institute, LLC, Cambridge Neue thrombolytische proteine.

Also Published As

Publication number Publication date
EP0234051B1 (de) 1991-12-11
JPS62192323A (ja) 1987-08-22
EP0234051A1 (de) 1987-09-02
DE3682891D1 (de) 1992-01-23

Similar Documents

Publication Publication Date Title
ATE70301T1 (de) Gewebeplasminogen-aktivator-mutant, dafuer kodierende rekombinante genetische information und verfahren zur herstellung dieser mutanten, deren verwendung und pharmazeutische zusammensetzungen.
FI862756A0 (fi) Fibroektiner.
ATE279430T1 (de) Verfahren zur verbesserung der serum halbwertszeit von biologisch aktiven molekülen
DE69018920D1 (de) Verwendung von dns-fragmenten, die ein signalpeptid kodieren zur sekretion von reifen proteinen in rekombinanten hefen, expressions-kassetten, transformierte hefen und verfahren zur herstellung dieser proteine.
KR850007275A (ko) 기능성 인체인자 ⅷ의 제조방법
ATE239079T1 (de) Gewebeinhibitor für metalloproteasen type 3 (timp-3)
DE3855921D1 (de) Verfahren und Desoxyribonukleinsäure zur Herstellung von Gewebefaktor-Protein
DE68928934D1 (de) Verfahren zur herstellung von menschlicher dnase
ATE140026T1 (de) Verfahren zur herstellung von thrombin und danach erhaltene hochgereinigte thrombinzusammensetzung
HU896005D0 (en) Process for producing plasminogen activator (t-pa) zymogenes of tissues and preparatives containing such active substances
NO176921C (no) Genteknologisk fremgangsmåte for fremstilling av et tPA-lignende protein, samt vertscelle som er i stand til å uttrykke et slikt protein
KR910003094A (ko) 흡혈박쥐속(Vampire bat) 타액 플라스미노겐 활성인자
ATE107960T1 (de) Varianten von menschlichem gewebeplasminogenaktivator sowie verfahren zu deren herstellung.
KR890003952A (ko) 신규 조직 플라스미노겐 활성제
DE3869230D1 (de) Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin.
DK0494929T3 (da) Mutanter af human plasminogenaktivatorinhibitor 1 (PAI-1), fremstilling og anvendelse deraf
ATE105862T1 (de) Methoden und materialien zur expression von varianten von menschlichem plasminogen.
ATE93273T1 (de) Neue fibrinolytische enzyme.
ATE194624T1 (de) Mutanten von menschlichem antithrombin iii
EP0302838A3 (en) Cloning of the gene coding the isoamylase enzyme and its use in the production of said enzyme
DK0517756T3 (da) Vævs-plasminogenaktivator med fibrinspecifikke egenskaber
DK0542869T3 (da) Vævsplasminogenaktivatorvarianter med nedsat udskillelse
EP0381331A3 (de) Gensequenzen, die modifizierte Reste in der Proteasedomäne des t-PAs codieren
KR870008588A (ko) 신규 인체 조직형 플라스미노겐 활성제 폴리펩티드
ATE114170T1 (de) Substitutionsvariante des gewebeplasminogenaktivators.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked